Peter Lynch on Investing: Stomach Over Brain, Time Horizon, and Professional Edge

Lynch's famous thesis that the most important organ for stock market investing is the stomach, not the brain. Emphasizes the critical question investors must answer: do you have faith that 10, 20, 30 years from now common stocks will be a good place to be? If you believe that, you should have money in equity funds. The key is understanding your tolerance for pain and ability to handle the constant stream of bad news.

Lynch argues against market timing and waiting for corrections. His key insight: 'More people lost money waiting for corrections and anticipating corrections than the actual corrections.' He advises investors to look in the mirror daily and ask what they'll do if the market goes down 10% or 20%. If the answer is to sell, they should reduce exposure today. Shares his Magellan track record: in 13 years, the market went down 10%+ nine times, and he went down more than the market every time - but didn't worry about it.

Lynch emphasizes the critical importance of matching investment vehicle to time horizon. The key questions: Do I need this money in a year? Two years? Three years? For the long term, stocks have been the best place to be - last 10 years, 30 years, 130 years. But if you need the money in one or two years, you shouldn't be buying stocks - you should be in a money market fund. Brief mention of emerging markets as potential research opportunity after being 'really hammered.'

Lynch reveals he never looked at the economy when investing. He focuses only on what's happening right now, not predictions about what will happen a year from now or what interest rates will be. His humorous take: 'I'd love to get next year's Wall Street Journal, I'd pay an extra dollar for it, that'd be very helpful. I don't know what's going on in the future but I want to find right now.' Emphasizes that anyone investing in the stock market must understand you buy a company, not lottery tickets.

Lynch illustrates how individual investors can have an edge over professionals through direct experience. Example: an interventional cardiologist using Abiomed's Impella device would see firsthand it's an incredible breakthrough for preventing shock and providing hemodynamic support. By actually using it in the operating room, the doctor sees this breakthrough way ahead of most people. 'That's an edge, you need an edge on something.' Emphasizes researching the company behind the stock - that's what Fidelity does, that's what he did at Magellan.

Lynch argues the individual investor's edge has actually improved over the last 23 years. In the past when they owned Nike, they had to wait for the mail to come to the library. Now when companies report earnings it's telecast globally, with investor presentations and balance sheets freely available. The data is much better and free. However, many people have too many biases - won't look at railroads, oil companies, steel companies, only want 40% growth companies, won't look at turnarounds. Lynch bought companies with unions and emphasizes the need to be agnostic and flexible. Fidelity's success comes from flexibility in what they'll look at.